[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Digestive Remedies in Indonesia

September 2023 | 23 pages | ID: DEF75B698F6EN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Diarrhoea is a common problem, but it is still the cause of many childhood deaths throughout the world, including in Indonesia. Apart from causing pain and even death, diarrhoea can also hinder a child’s growth and development, because it can cause stunting. Micronutrients that a child’s body needs to grow are lost due to repeated diarrhoeal infections. Data from the 2020 Indonesian Health Profile show that diarrhoea was the second largest contributor to death after pneumonia in babies aged 29 d...

Euromonitor International's Digestive Remedies in Indonesia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Digestive Remedies market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Digestive Remedies in Indonesia
Euromonitor International
September 2023

LIST OF CONTENTS AND TABLES

DIGESTIVE REMEDIES IN INDONESIA
KEY DATA FINDINGS

2023 DEVELOPMENTS

Diarrhoea remains a problem amongst children, driving sales of diarrhoeal remedies
Long-term impacts of COVID-19 continue to drive growth for digestive remedies
Kalbe Farma maintains its lead, but Phapros sees stronger growth
PROSPECTS AND OPPORTUNITIES
Busier lives and travel will contribute to continued growth, despite some challenges
Potential for Fexuprazan to be launched by Daewoong Pharmaceutical in Indonesia
Growth in e-commerce set to continue, but at a slower rate
CATEGORY DATA
Table 1 Sales of Digestive Remedies by Category: Value 2018-2023
Table 2 Sales of Digestive Remedies by Category: % Value Growth 2018-2023
Table 3 NBO Company Shares of Digestive Remedies: % Value 2019-2023
Table 4 LBN Brand Shares of Digestive Remedies: % Value 2020-2023
Table 5 Forecast Sales of Digestive Remedies by Category: Value 2023-2028
Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2023-2028
CONSUMER HEALTH IN INDONESIA
EXECUTIVE SUMMARY
Consumer health in 2023: The big picture

2023 KEY TRENDS

Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
Table 8 Life Expectancy at Birth 2018-2023
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2018-2023
Table 10 Sales of Consumer Health by Category: % Value Growth 2018-2023
Table 11 NBO Company Shares of Consumer Health: % Value 2019-2023
Table 12 LBN Brand Shares of Consumer Health: % Value 2020-2023
Table 13 Distribution of Consumer Health by Format: % Value 2018-2023
Table 14 Distribution of Consumer Health by Format and Category: % Value 2023
Table 15 Forecast Sales of Consumer Health by Category: Value 2023-2028
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources


More Publications